Newsletter | May 17, 2022

05.17.22 -- Digitalization In HPAPI Development & Manufacturing – Hype Or Valuable Toolbox?

Industry Insights
Digitalization In HPAPI Development And Manufacturing: Hype Or Valuable Toolbox?

A rapidly growing toolbox of digital technologies can be applied in many areas of both process development and production, which may help accelerate improvements in HPAPI production.

Effects Of The Ongoing Pandemic On Bupivacaine HCI Supply

Throughout the pandemic, painkiller and sedative demands have spiked. Drug manufacturers and CDMOs have become critical in efforts to stabilize the supply of Bupivacaine HCl and other essential drugs.

Tuning The Myeloid Compartment With A Best-In-Class CDMO

Cancer immunotherapy biotech Pionyr Immunotherapeutics needed to rapidly develop a third lead candidate from the start and to scale up manufacturing after tech transfer.

Master Analytical SEC Running Conditions

Need to find out how to calibrate your size exclusion chromatography (SEC) column? Or how different additives affect your results? Read these useful insights.

Scale-Up And Site Transfer Of A Semi-Solid Product For Commercial Launch

Any changes to the equipment and processes used to produce a semi-solid dosage form may affect the physicochemical characteristics, bioavailability, and sensory qualities of the final product.

Navigating Bioconjugate Development: A Q&A

Iwan Bertholjotti, director of commercial bioconjugate development, and Dr. Bernhard Stump, head of bioconjugate development, discuss complexity and uncertainty in the bioconjugates market.

Most Popular News
Life Science Leader Magazine

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.